Authors:
ROSTAING L
CHATELUT E
PAYEN JL
IZOPET J
THALAMAS C
TONTHAT H
PASCAL JP
DURAND D
CANAL P
Citation: L. Rostaing et al., PHARMACOKINETICS OF ALPHA-IFN-2B IN CHRONIC HEPATITIS-C VIRUS PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS OR WITH NORMAL RENAL-FUNCTION - CLINICAL IMPLICATIONS, Journal of the American Society of Nephrology, 9(12), 1998, pp. 2344-2348
Authors:
BELLO PY
PASQUIER C
GOURNEY P
PUEL J
IZOPET J
Citation: Py. Bello et al., ASSESSMENT OF A HEPATITIS-C VIRUS-ANTIBODY ASSAY IN SALIVA FOR EPIDEMIOLOGIC STUDIES, European journal of clinical microbiology & infectious diseases, 17(8), 1998, pp. 570-572
Citation: C. Pasquier et al., THE CONTRIBUTION OF MOLECULAR VIROLOGY TO THE UNDERSTANDING OF HIV-1 MOTHER-TO-CHILD TRANSMISSION, MS. Medecine sciences, 14(2), 1998, pp. 193-196
Citation: Jl. Payen et al., HEPATITIS-C REINFECTION AFTER INTRAVENOUS DRUG INJECTION, Gastroenterologie clinique et biologique, 22(4), 1998, pp. 469-470
Authors:
COMBIS JM
DESMORAT H
IZOPET J
BARANGE K
PAYEN JL
DANTIN S
MERICQ O
DUFFAUT M
VINEL JP
PASCAL JP
Citation: Jm. Combis et al., OFLOXACINE (OFL) AND INTERFERON-ALPHA (IFN) TREATMENT OF CHRONIC HEPATITIS-C - A PILOT-STUDY, Hepatology, 28(4), 1998, pp. 190-190
Authors:
TAMALET C
IZOPET J
KOCH N
FANTINI J
YAHI N
Citation: C. Tamalet et al., STABLE REARRANGEMENTS OF THE BETA-3-BETA-4 HAIRPIN LOOP OF HIV-1 REVERSE-TRANSCRIPTASE IN PLASMA VIRUSES FROM PATIENTS RECEIVING COMBINATION THERAPY, AIDS, 12(14), 1998, pp. 161-166
Authors:
ROSTAING L
MODESTO A
CISTERNE JM
IZOPET J
OKSMAN F
DUFFAUT M
ABBAL M
DURAND D
Citation: L. Rostaing et al., SEROLOGICAL MARKERS OF AUTOIMMUNITY IN RENAL-TRANSPLANT PATIENTS WITHCHRONIC HEPATITIS-C, American journal of nephrology, 18(1), 1998, pp. 50-56
Authors:
IZOPET J
PAYEN JL
ALRIC L
SANDRES K
CHARLET JP
VINEL JP
DUFFAUT M
PASCAL JP
PUEL J
Citation: J. Izopet et al., BASE-LINE LEVEL AND EARLY SUPPRESSION OF SERUM HCV RNA FOR PREDICTINGSUSTAINED COMPLETE RESPONSE TO ALPHA-INTERFERON THERAPY, Journal of medical virology, 54(2), 1998, pp. 86-91
Authors:
IZOPET J
TAMALET C
PASQUIER C
SANDRES K
MARCHOU B
MASSIP P
PUEL J
Citation: J. Izopet et al., QUANTIFICATION OF HIV-1 PROVIRAL DNA BY A STANDARDIZED COLORIMETRIC PCR-BASED ASSAY, Journal of medical virology, 54(1), 1998, pp. 54-59
Authors:
SEGONDY M
IZOPET J
PELLEGRIN I
MONTES B
DUMON B
PASQUIER C
PEETERS M
FLEURY HJA
PUEL J
REYNES J
Citation: M. Segondy et al., COMPARISON OF THE QUANTIPLEX HIV-1 RNA-2.0 ASSAY WITH THE AMPLICOR HIV-1 MONITOR-1.0 ASSAY FOR QUANTITATION OF LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA OF PATIENTS RECEIVING STAVUDINE-DIDANOSINE COMBINATION THERAPY, Journal of clinical microbiology (Print), 36(11), 1998, pp. 3392-3395
Authors:
ROSTAING L
IZOPET J
CISTERNE JM
ARNAUD C
DUFFAUT M
RUMEAU JL
PUEL J
DURAND D
Citation: L. Rostaing et al., IS LONG-TERM CHRONIC IMMUNOSUPPRESSION THERAPY DETRIMENTAL IN HEPATITIS-C VIRUS-POSITIVE RENAL-TRANSPLANT PATIENTS, Transplantation proceedings, 30(4), 1998, pp. 1312-1313
Authors:
ROSTAING L
IZOPET J
CISTERNE JM
ARNAUD C
DUFFAUT M
RUMEAU JL
PUEL J
DURAND D
Citation: L. Rostaing et al., IMPACT OF HEPATITIS-C VIRUS DURATION AND HEPATITIS-C VIRUS GENOTYPES ON RENAL-TRANSPLANT PATIENTS, Transplantation, 65(7), 1998, pp. 930-936
Authors:
PASQUIER C
CAYROU C
BLANCHER A
TOURNEPETHEIL C
BERREBI A
TRICOIRE J
PUEL J
IZOPET J
Citation: C. Pasquier et al., MOLECULAR EVIDENCE FOR MOTHER-TO-CHILD TRANSMISSION OF MULTIPLE VARIANTS BY ANALYSIS OF RNA AND DNA-SEQUENCES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virology (Print), 72(11), 1998, pp. 8493-8501
Authors:
DUVERLIE G
KHORSI H
CASTELAIN S
JAILLON O
IZOPET J
LUNEL F
EB F
PENIN F
WYCHOWSKI C
Citation: G. Duverlie et al., SEQUENCE-ANALYSIS OF THE NS5A PROTEIN OF EUROPEAN HEPATITIS-C VIRUS 1B ISOLATES AND RELATION TO INTERFERON SENSITIVITY, Journal of General Virology, 79, 1998, pp. 1373-1381
Authors:
PASQUIER C
BELLO PY
GOURNEY P
PUEL J
IZOPET J
Citation: C. Pasquier et al., A NEW-GENERATION OF SERUM ANTI-HIV ANTIBODY IMMUNOCAPTURE ASSAY FOR SALIVA TESTING, Clinical and diagnostic virology, 8(3), 1997, pp. 195-197
Authors:
IZOPET J
ROSTAING L
TONTHAT H
DUBOIS M
CAZABAT M
CHARLET JP
SAYADA C
DUFFAUT M
DURAND D
PUEL J
Citation: J. Izopet et al., KINETICS OF HCV VIREMIA IN KIDNEY-TRANSPLANT RECIPIENTS DURING AND AFTER ALPHA-INTERFERON THERAPY, American journal of nephrology, 17(5), 1997, pp. 417-420
Authors:
ROSTAING L
IZOPET J
CISTERNE JM
ICART J
CHABANNIER MH
PANICALI H
DURAND D
Citation: L. Rostaing et al., PREVALENCE OF ANTIBODIES TO HEPATITIS-C VIRUS AND CORRELATION WITH LIVER-DISEASE IN RENAL-TRANSPLANT PATIENTS, American journal of nephrology, 17(1), 1997, pp. 46-52
Authors:
ROSTAING L
IZOPET J
MOUSSION F
ALRIC L
VERDIER D
THAT HT
DUFFAUT M
DURAND D
PUEL J
SUC JM
Citation: L. Rostaing et al., HCV RNA CLEARANCE BY HEMODIALYSIS-PATIENT S WITH AND WITHOUT HGV HGBV-C INFECTION AFTER ALPHA-INTERFERON-THERAPY/, Nephrologie, 18(7), 1997, pp. 281-286
Authors:
HALFON P
POL S
SAYADA C
IZOPET J
ROSTAING L
OUZAN D
Citation: P. Halfon et al., CLINICAL-SIGNIFICANCE OF HCV RNA DETECTIO N AND QUANTITATION IN HEMODIALYSIS-PATIENTS - PROPOSAL FOR A RATIONAL DIAGNOSTIC STRATEGY, Nephrologie, 18(2), 1997, pp. 53-58
Authors:
KHORSI H
CASTELAIN S
WYSEUR A
IZOPET J
CANVA V
ROMBOUT A
CAPRON D
CAPRON JP
LUNEL F
STUYVER L
DUVERLIE G
Citation: H. Khorsi et al., MUTATIONS OF HEPATITIS-C VIRUS 1B NS5A-2209-2248 AMINO-ACID-SEQUENCE DO NOT PREDICT THE RESPONSE TO RECOMBINANT INTERFERON-ALFA THERAPY IN FRENCH PATIENTS, Journal of hepatology, 27(1), 1997, pp. 72-77
Authors:
BRUNVEZINET F
BOUCHER C
LOVEDAY C
DESCAMPS D
FAUVEAU V
IZOPET J
JEFFRIES D
KAYE S
KRZYANOWSKI C
NUNN A
SCHUURMAN R
SEIGNEURIN JM
TAMALET C
TEDDER R
WEBER J
WEVERLING GJ
ABER V
ABOULKER JP
BABIKER AG
BRAGMAN K
BRECKENRIDGE AM
CARBON C
CHARREAU I
CHENE G
COLLIS P
COOPER D
DARBYSHIRE JH
DORMONT J
FIDDIAN P
FLEPP M
GAZZARD B
GOEBEL FD
HOOKER M
LANGE J
LUTHY R
PETO TEA
REISS P
SELIGMANN M
STONE AB
THOMIS J
VELLA S
WALCKENAER G
WARRELL D
WELLER IVD
WILBER R
YENI P
YEO J
WITHNALL R
BABIKER A
BLOCH J
POUCHER C
DARBYSHIRE J
GOUDSMIT J
HURAUX JM
VANDERNOORDAA J
WEISS R
WEVERLING G
Citation: F. Brunvezinet et al., HIV-1 VIRAL LOAD, PHENOTYPE, AND RESISTANCE IN A SUBSET OF DRUG-NAIVEPARTICIPANTS FROM THE DELTA-TRIAL, Lancet, 350(9083), 1997, pp. 983-990
Authors:
BOGARD M
BUFFETJANVRESSE C
CANTALOUBE JF
BIAGINI P
DUVERLIE G
CASTELAIN S
IZOPET J
DUBOIS M
DEFER C
LEPOT I
COSTE J
MARCELLIN P
MARTINOTPEIGNOUX M
HALFON P
GEROLAMI V
FRANGUEL L
PAWLOTSKY JM
ROUDOTTHORAVAL F
DUSSAIX E
LOISEAU P
RAVERA N
LEWIN P
LAMORIL J
LERABLE J
BOUCHARDEAU F
LAPERCHE S
MARIOTTI M
LEFRERE JJ
NICOT T
DENIS F
GASSAIN M
MEREL P
TREPO C
THIERS V
BRECHOT C
FEREC C
MERCIER B
STOLLKELLER F
PALMER P
LEBON P
Citation: M. Bogard et al., GEMHEP MULTICENTER QUALITY-CONTROL STUDY OF PCR DETECTION OF GB-VIRUS-C HEPATITIS-G VIRUS-RNA IN SERUM, Journal of clinical microbiology, 35(12), 1997, pp. 3298-3300